NATR NATURES SUNSHINE PRODUCTS INC

8-K Current Report

Filed: March 10, 2026

Health Care

Pharmaceutical Preparations

NATURES SUNSHINE PRODUCTS INC (NATR) 8-K current report filed with SEC EDGAR on March 10, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure/Election of Directors or Officers

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q results press release furnished as exhibit; contains GAAP-to-non-GAAP reconciliation for period-over-period comparison
• Non-GAAP metrics highlighted by management as key lens for evaluating NATR's operating performance trends

Item 5.02 · Departure/Election of Directors or Officers

• CFO L. Shane Jones base salary raised from $478,400 to $492,752 (~3% increase), effective March 8, 2026
• EVP Asia Dan Norman base salary raised from $446,250 to $459,638 (~3% increase), effective March 8, 2026

+1 more insights

Get deeper insights on NATURES SUNSHINE PRODUCTS INC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.